Investigation of Drug Delivery of Mechlorethamine (Anticancer Drug) by Si76, C76, Al38N38 Nanocages
Source abstract
Abstract
Here, the potential of Si76, C76, Al38N38, V-Si76, V-C76 and V-Al38N38 nanocages to transfer the Mechlorethamine are examined by computational methods. Results shown that the water as polar solvent is increased the adsorption energy and enthalpy of Mechlorethamine on Si76, C76, Al38N38, V-Si76, V-C76 and V-Al38N38 nanocages ca 0.12 eV to 0.23 eV. Results shown that the HOMO of Mechlorethamine-nanocage complex is located on Mechlorethamine and LUMO of Mechlorethamine-nanocage complex is located on nanocages. The calculated ΔGadsorption of anticancer drug on Si76, C76, Al38N38, V-Si76, V-C76, V-Al38N38 are -3.06, -2.85, -2.97, -3.75, -3.53 and -3.61 eV. The V-Al38N38 and V-Si76 have higher Eadsorption to transfer the Mechlorethamine than C76 ca 0.17 eV to 0.21 eV. The recovery time (τ) values of complexes of V-Si76, V-C76, V-Al38N38 with anticancer drug are higher than Si76, C76 and Al38N38 ca 3.12 s to 5.49 s. Results indicated that the V-Al38N38 and V-Si76 are effective nanostructures to deliver the Mechlorethamine as anticancer drug.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Boron and Carbon Nanomaterials Research · Graphene research and applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Rana A, Pathak S (2023) ACS Appl Nano Mater 6:8106–813410.1021/acsanm.3c01351 ↗
2. Shi Li, Carn F, Boué F (2023) ACS Appl Nano Mater 6:3990–400410.1021/acsanm.3c00259 ↗
3. Mattern A, Habermann S (2022) Bioconjugate Chem 33:1741–174910.1021/acs.bioconjchem.2c00351 ↗
4. Yaraki MT (2022) Ind Eng Chem Res 61:7547–759310.1021/acs.iecr.2c00285 ↗
5. Wijesinghe KH (2021) J Phys Chem C 125:20488–2050210.1021/acs.jpcc.1c04228 ↗
6. Luo D, Johnson A (2020) Nano Lett 20:7159–716710.1021/acs.nanolett.0c02487 ↗
7. Shi Li, Carn F, Goukassov A (2020) Langmuir 36:7925–793210.1021/acs.langmuir.0c01064 ↗
8. Picardi G, Humbert B (2020) J Phys Chem C 124:11902–1191210.1021/acs.jpcc.0c01881 ↗
9. Zhang X, Guo X (2020) Chem Res Toxicol 33:1195–120510.1021/acs.chemrestox.9b00368 ↗
10. Chariou PL, Ortega-Rivera OA (2020) ACS Nano 14:2678–270110.1021/acsnano.0c00173 ↗
11. Lee S-Y, Shieh M-J (2020) ACS Appl Mater Interfaces 12:4254–426410.1021/acsami.9b18855 ↗
12. Pervee M, Khand M, Ayube K, Khanf M, Iqbal J (2020) Biophy Chem 267:10646110.1016/j.bpc.2020.106461 ↗
13. Alkhalifah MA, Yar M, Bayach I, Sheikh NS, Ayub K (2022) Materials 15:742510.3390/ma15217425 ↗
14. Asif M, Sajid H, Ayub K, Anwar N, Mahmood T (2023) J Mol Grap Modl 122:10846910.1016/j.jmgm.2023.108469 ↗
15. Fayyaz F, Yar M, Gulzar A, Ayub K (2022) J Mol Liq 356:11894110.1016/j.molliq.2022.118941 ↗
16. Ahsan F, Yar M, Gulzar A, Ayub K (2023) J Nanostruct Chem 13:89–10210.1007/s40097-022-00474-5 ↗
17. Chen Y, Zhang X-H (2020) ACS Nano 14:3640–365010.1021/acsnano.0c00118 ↗
18. Li D, Wang F, Di H (2019) Langmuir 35:8799–880510.1021/acs.langmuir.9b01325 ↗
19. Shin H-W, Sohn H (2019) Langmuir 35:6421–642810.1021/acs.langmuir.9b00406 ↗
20. Sztandera K, Gorzkiewicz M (2019) Mol Pharm 16:1–2310.1021/acs.molpharmaceut.8b00810 ↗
21. Rotz MW, Holbrook RJ (2018) Bioconjug Chem 29:3544–354910.1021/acs.bioconjchem.8b00504 ↗
22. Chakraborty S, Abbasi A (2018) Langmuir 34:13416–1342510.1021/acs.langmuir.8b02553 ↗
23. Wang H, Paul A (2018) ACS Appl Mater Interfaces 10:21808–2181510.1021/acsami.8b02461 ↗
24. Kang S, Shin W (2018) ACS Appl Mater Interfaces 10:13819–1382810.1021/acsami.8b01000 ↗
25. Bautista MCF, Shakerzadeh E, Anota EC (2022) J Mol Liquids 355:11898010.1016/j.molliq.2022.118980 ↗
26. Shakerzadeh E, Anota E, Nguyen MT (2022) Appl Organometl Chem 36:672110.1002/aoc.6721 ↗
27. Gholami, Shakerzadeh E, Bautista M (2023) Inorg Chem Commun 148:11032610.1016/j.inoche.2022.110326 ↗
28. Gholami, Shakerzadeh E, Anota EC (2023) Polyhedron 232:11629510.1016/j.poly.2023.116295 ↗
29. Zhao Y, Truhlar DG (2006) J Comput Chem Theory Comput 2:1009–101810.1021/ct060044j ↗
30. Becke D (1993) J Chem Phys 98:5648–564210.1063/1.464913 ↗
31. Stephens PJ, Devlin FJ, Chablowski CF (1994) J Phys Chem 98:11623–1162710.1021/j100096a001 ↗
32. Hertwig RH, Koch W (1997) Chem Phys Lett 268:345–35110.1016/S0009-2614(97)00207-8 ↗
33. Boese D, Martin JML, Handy NC (2003) J Chem Phys 119:3005–301410.1063/1.1589004 ↗
34. Zhao Y, Truhlar DG (2005) J Phys Chem A 109:5656–566710.1021/jp050536c ↗
35. Ferre-Vilaplana (2005) J Chem Phys 122:10470910.1063/1.1859278 ↗
36. Vilela Oliveira D, Laun J, Bredow T (2019) J Comput Chem 15:2364–237610.1002/jcc.26013 ↗
37. Wijesinghe KH (2020) J Phys Chem Lett 11:6312–631910.1021/acs.jpclett.0c01330 ↗
38. Zhao W, Suo H, Wang S, Ma L, Wang L (2022) J Eur Ceram Soc 42:7036–704810.1016/j.jeurceramsoc.2022.08.029 ↗
39. Song X, Li Q, Zhang J (2023) Biomed Pharmacother 162:11461110.1016/j.biopha.2023.114611 ↗
40. Wang Y, Zhai W, Cheng S et al (2023) Friction 11:1371–139410.1007/s40544-022-0710-x ↗
41. Wang Y, Zhai W, Li J, Liu H (2023) Tribol Int 188:10889110.1016/j.triboint.2023.108891 ↗
42. Xia J, Li Y, He C, Yong C, Wang L (2023) ACS Infect Dis 9:1711–172910.1021/acsinfecdis.3c00162 ↗
43. Wang Y, Li C, Shen B, Zhu L (2023) Chem Eng J 466:14329210.1016/j.cej.2023.143292 ↗
44. Liu Y, Dong T, Chen Y, Sun N, Liu Q (2023) ACS Appl Mater Interfaces 15:11507–1151910.1021/acsami.2c20401 ↗
45. Huang H, Zhang B, Zhong J, Han G, Zhang J (2023) Med Eng Phys 113:10396610.1016/j.medengphy.2023.103966 ↗
46. Hu F, Shi X, Wang H, Nan N, Wang K (2021) Front Public Health 9:69174610.3389/fpubh.2021.691746 ↗
47. Zheng J, Yue R, Yang R, Wu Q, Wu Y (2022) Front Bioeng Biotechnol 10:94051110.3389/fbioe.2022.940511 ↗